How can you buy Regeneron shares?
Regeneron is a pharmaceutical company that has already developed several interesting medicines. Regeneron is also investigating a new potential remedy against the coronavirus. Do you want to buy Regeneron shares? In this article we look at how to achieve the best results with investments in Regeneron.
How to buy Regeneron stocks?
Do you think Regeneron will deliver even better results in the future? Then it can be smart to invest in the company by buying the shares for the long term. This can be done at eToro, as this broker does not calculate fixed commissions for US stocks. Use the button below to open an account directly with eToro:Your capital is at risk. Other fees apply. For more information, visit etoro.com/trading/fees.
How to actively invest in Regeneron?
A stock like Regeneron can be very volatile: When news comes out about new medicines, the share price can suddenly rise sharply. When a new drug is rejected, the price can fall. As an active investor or trader, you can respond to these types of developments.
A good broker where you can take advantage of the volatility of the Regeneron CFD share is Plus500. At Plus500 you can try trading completely free & without risk with a demo. Use the button below to open a free demo at Plus500 immediately:72% of retail CFD accounts lose money.
What is Regeneron’s stock price?
Do you want to know how Regeneron’s stock price is developing? In the chart below you can see at what price you can buy Regeneron CFD-shares:
Is it wise to invest in Regeneron?
Regeneron is often listed with companies that suddenly produce good results because of the coronavirus. However, the company is not entirely interested in this: Regeneron has developed enough other products to be an interesting investment. This can also be seen in the performance of the stock: the company is a lot less volatile than, for example, Novavax, which increased more than 4000% in value, but later dropped 30% in value again.
A corona drug can therefore be a positive for Regeneron, but even without a new drug, the company benefits from profitability. Consequently, you can consider an investment in Regeneron.
In short about Regeneron
The headquarters of US biotechnology company Regeneron Pharmaceuticals is located in Eastview. This city in the U.S. state of Tennessee is located near New York. The company, which has only one business segment, is committed to the development, production, and marketing of medicines.
Regeneron drug developments
Regeneron was founded in 1998 and has grown into a company with multiple branches. Regeneron is known worldwide as a developer of various medicines for serious and life-threatening diseases. By marketing groundbreaking recipes such as a VEGF inhibitor and an interleukin blocker, Regeneron is seen as a company that mastered its profession.
The company now conducts a study to the cynatin and to recipes based on tyrosine kinase. This company, which has close ties to the pharmaceutical companies Bayer and Sanofi, employs more than 6,000 people worldwide.
When considering an investment in Regeneron, it is important to keep a close eye on the company’s drug developments. Once Regeneron succeeds in bringing a new, promising drug to market, the stock price can rise sharply. This could be an interesting time to buy Regeneron shares.
Do you want to invest in Regeneron? That is possible! The company is listed as REGN on the U.S. Nasdaq.
Development of an agent against corona
The American pharmaceutical company Regeneron is developing a possible drug against the COVID-19 virus. The company received an order of $450 million from the U.S. government. The drug, a cocktail of antiviral antibodies, is currently being tested.
It is being tested whether the drug can be used to treat patients infected with the COVID-19 virus and whether it can prevent infection with this virus. Since spring 2020, the company has increased the production of this product at its own risk. The US government order allows the company to increase production even further. If, after the clinical trial phase, the product is authorized to be brought to market, then the drug will be widely available.
These types of developments can have a strong influence on the share price. When considering an investment in the company, it is wise to pay attention to this.
Trump’s experimental corona treatment
After U.S. President Donald Trump tested positive for coronavirus, he was treated with an experimental cocktail of synthetic antibodies. The president received a dose of 8 mm of experimental drug REGN-COV2 developed by Regeneron. After his quick recovery, he praised Regeneron to the sky: The share trades 60% higher in October 2020 than at the beginning of 2020.